1. Are Patients With Inflammatory Bowel Disease at an Increased Risk of Developing SARS-CoV-2 than Patients Without Inflammatory Bowel Disease? Results From a Nationwide Veterans' Affairs Cohort Study. (19th April 2021) Authors: Khan, Nabeel; Patel, Dhruvan; Xie, Dawei; Pernes, Tyler; Lewis, James; Yang, Yu-Xiao Journal: American journal of gastroenterology Issue: Volume 116:Number 4(2021) Page Start: 808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of Vedolizumab in a Nationwide Cohort of Elderly Inflammatory Bowel Disease Patients. Issue 5 (10th July 2021) Authors: Khan, Nabeel; Pernes, Tyler; Weiss, Alexandra; Trivedi, Chinmay; Patel, Manthankumar; Medvedeva, Elina; Xie, Dawei; Yang, Yu-Xiao Journal: Inflammatory bowel diseases Issue: Volume 28:Issue 5(2022) Page Start: 734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Incidence of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Patients With Inflammatory Bowel Disease and the Impact of Thiopurines on Their Risk. (26th April 2021) Authors: Khan, Nabeel; Patel, Dhruvan; Trivedi, Chinmay; Kavani, Himanshu; Pernes, Tyler; Medvedeva, Elina; Lewis, James; Xie, Dawei; Yang, Yu-Xiao Journal: American journal of gastroenterology Issue: Volume 116:Number 4(2021) Page Start: 741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Repeated Occurrences of Basal Cell Cancer in Patients With Inflammatory Bowel Disease Treated With Immunosuppressive Medications. (August 2020) Authors: Khan, Nabeel; Patel, Dhruvan; Trivedi, Chinmay; Kavani, Himanshu; Medvedeva, Elina; Pernes, Tyler; Xie, Dawei; Lewis, James; Yang, Yu-Xiao Journal: American journal of gastroenterology Issue: Volume 115:Number 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. S0792 The Safety of Switching From Originator Infliximab or Biosimilar CT-P13 to SB2 Among a Nationwide Cohort of Inflammatory Bowel Disease Patients. (October 2020) Authors: Pernes, Tyler; Patel, Manthankumar; Khan, Nabeel Journal: American journal of gastroenterology Issue: Volume 115:Supplement(2020)ACG Annual Meeting Abstracts 1 Page Start: S405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease. (29th March 2022) Authors: Khan, Nabeel; Trivedi, Chinmay; Aberra, Faten; Pernes, Tyler; Yang, Yu-Xiao Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 9(2022) Page Start: 1505 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The Efficacy and Safety of Switching From Originator Infliximab to Single or Double Switch Biosimilar Among a Nationwide Cohort of Inflammatory Bowel Disease Patients. Issue 2 (26th April 2021) Authors: Khan, Nabeel; Patel, Dhruvan; Pernes, Tyler; Patel, Manthankumar; Trivedi, Chinmay; Medvedeva, Elina; Xie, Dawei; Yang, Yu-Xiao Journal: Crohn's & colitis 360 Issue: Volume 3:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The impact of IBD medications on risk of pneumonia and pneumonia‐related hospitalisation: a nationwide cohort study of 56 410 IBD patients. Issue 1 (19th October 2021) Authors: Khan, Nabeel; Patel, Dhruvan; Trivedi, Chinmay; Pernes, Tyler; Kavani, Himanshu; Xie, Dawei; Yang, Yu‐Xiao Journal: Alimentary pharmacology & therapeutics Issue: Volume 55:Issue 1(2022) Page Start: 64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗